KFY Form 144: Executive to sell 31,784 shares on NYSE

Rhea-AI Filing Summary

Form 144 notice for KFY shows a proposed sale of 31,784 shares of common stock on 10/08/2025 through Merrill Lynch on the NYSE, with an aggregate market value of $2,243,771. The shares were acquired as a restricted stock award on 07/11/2025 and were granted as executive compensation. The filer also reported a prior sale of 28,352 shares on 10/07/2025 for $2,001,970. The notice includes the required attestation that the seller is not aware of undisclosed material adverse information.

Positive

• Securities were acquired as restricted stock awards tied to executive compensation, indicating alignment with company incentives
• Sale conducted through a major broker (Merrill Lynch) on the NYSE, suggesting standard market execution procedures

Negative

• Concentrated insider selling within a short window (sales on 10/07/2025 and planned on 10/08/2025)
• The sold shares equal ~0.061% of outstanding shares (31,784 of 52,390,986), creating modest near‑term dilution/liquidity impact

Insights

Equity Compensation Analyst

Insider selling of recently issued restricted shares signals planned liquidity, not necessarily negative performance.

The filing shows a planned open‑market sale of 31,784 restricted shares granted on 07/11/2025 as executive compensation, executed through Merrill Lynch on 10/08/2025. Such sales often reflect tax or diversification needs after vesting rather than operational concerns.

Key dependency is the size of the sale relative to total outstanding shares (52,390,986). Monitor short time between grant and sale dates and the prior sale of 28,352 shares on 10/07/2025 for near‑term dilution and insider liquidity over the next days.

Market Microstructure Specialist

Transaction scale is modest but could slightly pressure intraday liquidity around execution dates.

The aggregate values reported—$2,243,771 and prior $2,001,970—are small relative to many large‑cap trading volumes, limiting market impact. Execution through a major broker (Merrill Lynch) indicates standard open‑market handling.

Watch trade timing and block execution details on 10/08/2025 to see if orders are split or cross‑matched; this affects short‑term price impact within the following trading session.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 2049 CENTURY PARK EAST SUITE 1200 LOS ANGELES CA 90067	31784	2243771	52390986	10/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	07/11/2025	RESTRICTED STOCK AWARD	KORN FERRY			31784	07/11/2025	EXECUTIVE COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
GARY BURNISON 1900 AVENUE OF THE STARS SUITE 1500 LOS ANGELES CA 90067	COMMON	10/07/2025	28352	2001970

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the KFY Form 144 disclose about planned insider sales?

It discloses a proposed sale of 31,784 common shares on 10/08/2025 through Merrill Lynch with an aggregate market value of $2,243,771.

When were the shares to be sold by the KFY insider acquired?

The shares were acquired as a restricted stock award on 07/11/2025 and listed as executive compensation.

Has the insider sold KFY shares recently before this Form 144?

Yes; the filing reports a prior sale of 28,352 shares on 10/07/2025 for $2,001,970.

How large is the proposed sale relative to KFY's outstanding shares?

The proposed sale of 31,784 shares is out of 52,390,986 outstanding shares, about 0.061% of the float.

Does the Form 144 state any undisclosed adverse information?

The signer represents they do not know any material adverse information that has not been publicly disclosed.